Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,061 to 2,080 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microfabric Vessels for Embryoid Body Formation and Rapid Differentiation of Pluripotent Stem Cells. | Sci Rep | 2016 | 27507707 | PubTator, text mining | PubMed |
| Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization. | PLoS One | 2016 | 27501229 | PubTator, text mining | PubMed |
| Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors. | Oncoscience | 2016 | 27489863 | PubTator, text mining | PubMed |
| Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo. | Mol Cancer | 2016 | 27473374 | PubTator, text mining | PubMed |
| Aberrant transcriptional networks in step-wise neurogenesis of paroxysmal kinesigenic dyskinesia-induced pluripotent stem cells. | Oncotarget | 2016 | 27449084 | PubTator, text mining | PubMed |
| Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences. | J Proteome Res | 2016 | 27447733 | PubTator, text mining | PubMed |
| Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma. | Oncotarget | 2016 | 27447573 | PubTator, text mining | PubMed |
| Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial. | JAMA Cardiol | 2016 | 27437887 | PubTator, text mining | PubMed |
| Progress and perspective of TBX6 gene in congenital vertebral malformations. | Oncotarget | 2016 | 27437870 | PubTator, text mining | PubMed |
| Molecular gene signature and prognosis of non-small cell lung cancer. | Oncotarget | 2016 | 27437769 | PubTator, text mining | PubMed |
| [Application of systematic etiological analysis in final and differential diagnosis of hereditary hemolytic anemia]. | Zhonghua Xue Ye Xue Za Zhi | 2016 | 27431078 | PubTator, text mining | PubMed |
| Differentiation of Bone Marrow: Derived Mesenchymal Stem Cells into Hepatocyte-like Cells. | Indian J Hematol Blood Transfus | 2016 | 27429519 | PubTator, text mining | PubMed |
| The transcriptomes of novel marmoset monkey embryonic stem cell lines reflect distinct genomic features. | Sci Rep | 2016 | 27385131 | PubTator, text mining | PubMed |
| Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment. | Oncotarget | 2016 | 27384874 | PubTator, text mining | PubMed |
| Utility of Lymphoblastoid Cell Lines for Induced Pluripotent Stem Cell Generation. | Stem Cells Int | 2016 | 27375745 | PubTator, text mining | PubMed |
| Intrinsic FGF2 and FGF5 promotes angiogenesis of human aortic endothelial cells in 3D microfluidic angiogenesis system. | Sci Rep | 2016 | 27357248 | PubTator, text mining | PubMed |
| Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol. | PLoS One | 2016 | 27355345 | PubTator, text mining | PubMed |
| Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model. | Oncol Rep | 2016 | 27350037 | PubTator, text mining | PubMed |
| Improvement of mesenchymal stem cell differentiation into the endoderm lineage by four step sequential method in biocompatible biomaterial. | Bioimpacts | 2016 | 27340619 | PubTator, text mining | PubMed |
| How to Grow a Lung: Applying Principles of Developmental Biology to Generate Lung Lineages from Human Pluripotent Stem Cells. | Curr Pathobiol Rep | 2016 | 27340610 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=104